Neutralizing TGFβ in vivo causes remodeling of CAF dynamics, reduces the frequency and activity of myofibroblasts, promotes the formation of immunomodulatory fibroblasts with a strong response to interferon and the development of productive anti-tumor immunity [539]. The gene discussed is TGFB1; the disease is neoplasm.